# CN Healthy Food Tech Group Corp.: overview

UCFI · Nasdaq · CIK 1901203 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ucfi.md) · [Financials](/companies/ucfi/financials.md) · [Filings](/companies/ucfi/filings.md) · [Insiders](/companies/ucfi/insiders.md)

Latest reported revenue: [$8.7m](/filings/0001213900-26-089578.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-089578).

## Last eight quarters

| Line item | Unit | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | not reported | [4,292](/filings/0001213900-25-112657.md) | not reported | [4,823](/filings/0001213900-26-055809.md) | [7,460](/filings/0001213900-26-089578.md) | [7,905](/filings/0001213900-25-112657.md) | [5,829](/filings/0001213900-26-055809.md) | [8,734](/filings/0001213900-26-089578.md) |
| Gross margin | % | not reported | [68.7%](/filings/0001213900-25-112657.md) | not reported | [48.9%](/filings/0001213900-26-055809.md) | [66.3%](/filings/0001213900-26-089578.md) | [70.4%](/filings/0001213900-25-112657.md) | [74.9%](/filings/0001213900-26-055809.md) | [71.5%](/filings/0001213900-26-089578.md) |
| Operating margin | % | not reported | [53.5%](/filings/0001213900-25-112657.md) | not reported | [16.7%](/filings/0001213900-26-055809.md) | [51.9%](/filings/0001213900-26-089578.md) | [58.0%](/filings/0001213900-25-112657.md) | [12.5%](/filings/0001213900-26-055809.md) | [58.6%](/filings/0001213900-26-089578.md) |
| Net margin | % | not reported | [36.5%](/filings/0001213900-25-112657.md) | not reported | [16.0%](/filings/0001213900-26-089578.md) | [39.2%](/filings/0001213900-26-089578.md) | [42.3%](/filings/0001213900-25-112657.md) | [(5.3%)](/filings/0001213900-26-089578.md) | [35.0%](/filings/0001213900-26-089578.md) |
| Diluted EPS | $ per share | not reported | [0.04](/filings/0001213900-25-112657.md) | not reported | [0.02](/filings/0001213900-26-055809.md) | [0.06](/filings/0001213900-26-089578.md) | [0.07](/filings/0001213900-25-112657.md) | [(0.01)](/filings/0001213900-26-055809.md) | [0.06](/filings/0001213900-26-089578.md) |
| Free cash flow | $k | not reported | not reported | not reported | [(239)](/filings/0001213900-26-055809.md) | [(1,501) d](/filings/0001213900-26-089578.md) | [(4,412) d](/filings/0001213900-25-112657.md) | [(3,601)](/filings/0001213900-26-055809.md) | [(7,031) d](/filings/0001213900-26-089578.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported |
| Diluted EPS | $ per share | not reported | not reported | not reported |
| Free cash flow | $ | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ucfi/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BOOTHBAY FUND MANAGEMENT, LLC](/funds/1549230.md) | 2026-06-30 | $1.5m | 278,320 |  | Unchanged |
| [RIVERNORTH CAPITAL MANAGEMENT, LLC](/funds/1447578.md) | 2026-06-30 | $559.3k | 101,506 |  | Unchanged |
| [AQR Arbitrage LLC](/funds/1167456.md) | 2026-06-30 | $501.7k | 91,050 |  | Unchanged |
| [Westchester Capital Management, LLC](/funds/1512805.md) | 2026-06-30 | $268.4k | 48,718 |  | Unchanged |
| [WHITEBOX ADVISORS LLC](/funds/1257391.md) | 2026-06-30 | $165.3k | 30,000 |  | Unchanged |
| [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $131.2k | 23,807 |  | Unchanged |
| [Yakira Capital Management, Inc.](/funds/1584639.md) | 2026-06-30 | $114.3k | 20,741 |  | Unchanged |
| [ARISTEIA CAPITAL, L.L.C.](/funds/1080171.md) | 2026-06-30 | $92.8k | 16,840 |  | Unchanged |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $55.6k | 10,080 |  | Unchanged |
| [Bulldog Investors, LLP](/funds/1504304.md) | 2026-06-30 | $50.2k | 10,919 |  | New +10,919 |

## Recent filings

[All 117 filings](/companies/ucfi/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-13 | 17:15 ET | [8-K](/filings/0001213900-26-109099.md) | 3.01 Delisting notice | 0001213900-26-109099 |
| 2026-08-14 | 10:50 ET | [10-Q](/filings/0001213900-26-089578.md) | Quarterly report, period 2026-06-30 | 0001213900-26-089578 |
| 2026-07-21 | 16:20 ET | [8-K](/filings/0001213900-26-080024.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-080024 |
| 2026-06-12 | 16:30 ET | [10-K/A](/filings/0001213900-26-068310.md) | Annual report, amended, period 2025-12-31 | 0001213900-26-068310 |
| 2026-05-13 | 16:15 ET | [10-Q](/filings/0001213900-26-055809.md) | Quarterly report, period 2026-03-31 | 0001213900-26-055809 |
| 2026-04-29 | 06:06 ET | [8-K](/filings/0001213900-26-048800.md) | 8.01 Other events | 0001213900-26-048800 |
| 2026-03-31 | 17:23 ET | [10-K](/filings/0001213900-26-037655.md) | Annual report, period 2025-12-31 | 0001213900-26-037655 |
| 2025-11-19 | 16:31 ET | [10-Q](/filings/0001213900-25-112657.md) | Quarterly report, period 2025-09-30 | 0001213900-25-112657 |
| 2025-10-06 | 17:26 ET | [8-K](/filings/0001213900-25-096652.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-096652 |
| 2025-09-30 | 16:52 ET | [8-K](/filings/0001213900-25-094023.md) | 8.01 Other events | 0001213900-25-094023 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-037655.md), filed Mar 31, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/eb6c3075-2d6a-4a3a-ab58-88235a9576a7)

## About the filer

- CIK: 1901203
- Tickers: UCFI, UCFIW
- Exchange: Nasdaq
- SIC code: 2000 Food and Kindred Products
- State of incorporation: DE
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 17:08 ET. No prices; not investment advice.